Impact of Zinc Supplementation on Phenotypic Antimicrobial Resistance of Fecal Commensal Bacteria from Pre-Weaned Dairy Calves
-
2024/02/23
-
Details
-
Personal Author:
-
Description:The objective of this study was to evaluate the impact of dietary zinc supplementation in pre-weaned dairy calves on the phenotypic antimicrobial resistance (AMR) of fecal commensal bacteria. A repository of fecal specimens from a random sample of calves block-randomized into placebo (n= 39) and zinc sulfate (n= 28) groups collected over a zinc supplementation clinical trial at the onset of calf diarrhea, calf diarrheal cure, and the last day of 14 cumulative days of zinc or placebo treatment were analyzed. Antimicrobial susceptibility testing was conducted for Enterococcus spp. (n= 167) and E. coli (n= 44), with one representative isolate of each commensal bacteria tested per sample. Parametric survival interval regression models were constructed to evaluate the association between zinc treatment and phenotypic AMR, with exponentiated accelerated failure time (AFT) coefficients adapted for MIC instead of time representing the degree of change in AMR (MIC Ratio, MR). Findings from our study indicated that zinc supplementation did not significantly alter the MIC in Enterococcus spp. for 13 drugs: gentamicin, vancomycin, ciprofloxacin, erythromycin, penicillin, nitrofurantoin, linezolid, quinupristin/dalfopristin, tylosin tartrate, streptomycin, daptomycin, chloramphenicol, and tigecycline (MR= 0.96-2.94, p > 0.05). In E. coli, zinc supplementation was not associated with resistance to azithromycin (MR= 0.80, p > 0.05) and ceftriaxone (MR= 0.95, p > 0.05). However, a significant reduction in E. coli MIC values was observed for ciprofloxacin (MR= 0.17, 95% CI 0.03-0.97) and nalidixic acid (MR= 0.28, 95% CI 0.15-0.53) for zinc-treated compared to placebo-treated calves. Alongside predictions of MIC values generated from these 17 AFT models, fundings from this study corroborate the influence of age and antimicrobial exposure on phenotypic AMR. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:2045-2322
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:14
-
NIOSHTIC Number:nn:20069281
-
Citation:Sci Rep 2024 Feb; 14:4448
-
Contact Point Address:Sharif S. Aly, Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA
-
Email:saly@ucdavis.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2024
-
NORA Priority Area:
-
Performing Organization:University of California - Davis
-
Peer Reviewed:True
-
Start Date:20010930
-
Source Full Name:Scientific Reports
-
End Date:20270929
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ecc8f1c6a5d1a16b5942f6a483e25bd8e60f464329913790812a4a68747e6721b3848065488e0bad5bfbc24d01b66cc0b27ffe2ea8ace57f23b1db04f5336588
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like